Article Text

Download PDFPDF

Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome
Free
  1. D S Gill,
  2. K Ng,
  3. K-S Ng
  1. Department of Cardiology, The Heart Institute, Tan Tock Seng Hospital, Singapore
  1. Correspondence to:
    Dr D Gill
    Department of Cardiology, The Heart Institute, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433; dal3hotmail.com

Abstract

Antiplatelet medications such as clopidogrel and tirofiban (glycoprotien IIb/IIIa inhibitors) are associated with a reduction in mortality and morbidity and are therefore recommended in the treatment of acute coronary syndromes. Massive pulmonary haemorrhage is a rare complication of both clopidogrel and tirofiban. Pulmonary haemorrhage may easily be mistaken for acute pulmonary oedema, a condition commonly seen in patients with acute coronary syndrome. Physicians need to be aware of this diagnostic dilemma because early treatment increases the chances of patient survival.

  • pulmonary haemorrhage
  • acute coronary syndrome
  • clopidogrel
  • tirofiban
View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.